📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial. (2023)

First Author: Joharatnam-Hogan N

Attributed to: Developing Existing Healthcare Technologies to Deliver More Affordable and Effective Cancer Care funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41416-023-02310-1

PubMed Identifier: 37420000

Publication URI: http://europepmc.org/abstract/MED/37420000

Type: Journal Article/Review

Volume: 129

Parent Publication: British journal of cancer

Issue: 4

ISSN: 0007-0920